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ABSTRACT 
This study reports two cases of chronic paracoccidioidomycosis with sarcoid-like cutaneous 
lesions. The patients began the treatment in 2013 at Hospital Universitário Clementino Fraga 
Filho (HUCFF) of the Universidade Federal do Rio de Janeiro (UFRJ). The first case (mild form) 
was treated with trimethoprim-sulfamethoxazole (8 mg /kg per day, orally) for three months 
and, then, with half the dose for nine months; the second (moderate form), with itraconazole 
(200 mg per day, orally) for 12 months. We point out the rareness of the sarcoid-like cutaneous 
lesions and the differential diagnoses for other granulomatous diseases. 
KEYWORDS: Paracoccidioidomycosis. Sarcoidosis. Epidemiology. Diagnosis. 
Classification.
INTRODUCTION
Paracoccidiodomycosis is a systemic mycosis with acute and chronic progression, 
caused by Paracoccidioides species. Studies reveal that the male/female rate is 6:1; 
there is a prevalence of the chronic clinical form in adults (74.6%); the absolute 
majority of patients have a rural life history (93.5%), with high rates of smoking 
(64.7%) and alcohol abuse (37.2%)1,2.
Sarcoidosis is a systemic disease of unknown cause, characterized by the 
formation of epithelioid cell granulomas in the affected organs. It affects men and 
women of all races and ages, usually between 20 and 40 years old, with a slight 
predominance in women.
The morphological variety of the sarcoidosis lesions leads to the following 
differential diagnoses: secondary/tertiary syphilis, granuloma annulare, tuberculoid 
leprosy, lupus vulgaris and lupus erythematosus3.
Paracoccidiodomycosis can manifest itself through sarcoid-like cutaneous 
lesions4-6, i.e., well-defined and infiltrative lesions, generally in the cephalic pole. 
According to the description of Brazilian adults4, histology in these cases shows a 
tuberculoid, granulomatous, inflammatory pattern with a paucity of fungi. Patients 
are young and may have cervical lymph nodes, but the overall condition is good. 
Skin lesions in paracoccidioidomycosis occur in 30-54% of patients4. They are 
most commonly located on the face with an ulcerative-vegetative pattern, usually 
followed by infiltration4,7.
FIRST CASE REPORT
A 49 years old, male, metallurgical employee born and raised in Nova Iguaçu 
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(urban area), Rio de Janeiro State. This case evolved 
for four months with injuries on the face, scalp, and 
right preauricular region. He showed no lesions in the 
oral mucosa. The patient was examined by a private 
physician who, due to a positive ANA test (1/160) and 
cutaneous involvement, began treatment for systemic lupus 
erythematosus (SLE) with oral hydroxychloroquine 400 mg 
each day and prednisone 40 mg per day. 
In May 2013, the patient was referred to Hospital 
Universitário Clementino Fraga Filho (HUCFF) of the 
Universidade Federal do Rio de Janeiro (UFRJ), more 
precisely to the Dermatology Service; he had been sick 
since December, 2012.
He denied drinking alcohol and smoking. Dermatological 
examination indicated erythematous infiltrated, ulcerated, 
and crusted lesion in left malar region, and ulcerous-
vegetating lesion on the right preauricular region (Figure 1A). 
Complete blood count, liver and renal functions, erythrocyte 
sedimentation rate (ESR), anti-HIV serology, anti-Sm, anti-
DNA, and chest X-ray (PA and lateral) were requested. The 
results showed: normal values for blood count, liver and 
renal functions, and erythrocyte sedimentation rate; negative 
anti-HIV serology; negative anti-Sm; negative anti-DNA; 
and normal chest X-ray. Weaning from prednisone was 
started and hydroxychloroquine was suspended.
The histopathological examination of skin fragment 
obtained by biopsy revealed fungal elements (Figure 2).
The biopsy material was placed on a slide with a 
drop of black ink Parker +20% potassium hydroxide 
(KOH) solution, examined under the microscope, and 
revealed the yeast cells: multiple buds attached to 
the mother cell (resembling a pilot’s wheel) by very 
narrow necks, characteristic of Paracoccidioides spp. 
(Figure 3).
The clinical presentation of the disease was evaluated as 
mild by the following parameters: absence of fever, loss of 
weight, palpable lymph nodes, and pulmonary involvement, 
no impairment of general condition. Trimethoprim 
sulfamethoxazole was initiated at an oral dose of 8 mg/kg/day 
(trimethoprim) for three months and, then, half of the dose 
for nine months2. There was complete regression of the 
lesions before six months (Figure 1B).
SECOND CASE REPORT
A 56 years old, male, machine operator, born and 
raised in Itatiaia (urban area), Rio de Janeiro State. The 
disease started in November 2012 with bilateral cervical 
lymphadenopathy, associated with node suppuration and 
fever. After six months, the patient was referred to Hospital 
Universitário Clementino Fraga Filho (HUCFF) of the 
Universidade Federal do Rio de Janeiro (UFRJ), more 
Figure 1 - (A) Erythematous infiltrated plaque, crusted and 
ulcerated on the left malar area; (B) Complete involution of the 
lesions after six months’ treatment (Case 1)
Figure 2 - Chronic granulomatous inflammation with yeast cells 
inside multinucleated giant cells. H&E (x40) (Case 1)
Figure 3 - Direct examination: -globular cells with thick walls and 
multiple budding. Black ink Parker with 20% KOH-(40x) (Case 1)
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precisely to the Dermatology Service, due to erythematous-
violaceous infiltrated plaques, some scaly on the face, trunk 
and limbs (Figure 4A). Complete blood count, erythrocyte 
sedimentation rate, liver and renal functions, anti-HIV 
serology, and chest X-ray (PA and lateral) were requested. 
The results showed: normal values for blood count, 
erythrocyte sedimentation rate, liver and renal functions; 
negative anti-HIV serology; normal chest X-ray. 
The histopathological examination of skin fragment 
obtained by biopsy revealed scarce, round and smooth, 
fungal elements (Figure 5).
In order to isolate the fungus, the material from skin 
biopsy was plated on Sabouraud’s agar and incubated at 
25-30 ºC.
Conversion of the mycelial culture to the yeast form in 
vitro was achieved by transferring into brain-heart infusion 
and incubating at 37 ºC for 20 days with profuse yeast 
cells bud production, characteristic of Paracoccidioides 
spp. (Figure 6).
The clinical presentation of the disease was evaluated 
as moderate by the parameters fever and suppurative 
lymphadenopathy. Thus, itraconazole was initiated at an 
oral dose of 200 mg after lunch, in a single administration 
per day for 12 months. There was complete regression of 
the disease2 (Figure 4B).
DISCUSSION 
One of the described patients was referred to HUCFF 
with a diagnosis of cutaneous lupus erythematosus, in use 
of oral corticosteroids and hydroxychloroquine. In the 
tumid variety, the lesions are edematous and infiltrated 
with erythematous surface of varying sizes. It is the clinical 
form, which includes sarcoidosis as a differential diagnosis. 
In chronic lupus erythematosus, the main age distribution 
is adults aged 20-40 and above 70. It is more common in 
Caucasian women in the proportion of 3.4:1.0. 
Despite the rareness of ulcerative lesions in sarcoidosis, 
they may occur (first case), as already reported in the 
literature8,9. 
Some authors4,5,6 believe that the sarcoid form 
is determined by good specific immunity against 
Paracoccidiodes spp. The biggest challenge in infectious 
granulomatous diseases without obvious etiology is 
endurance and persistence in research until the agent is 
found4, besides the inherent difficulties in the diagnosis of 
cutaneous sarcoidosis itself.
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Figure 4 - (A) Erythematous violaceous and infiltrated plaques 
of face, trunk and limbs; (B) Regression of the lesions after six 
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Figure 5 - Rare globular, regular, fungal cells. Silver (x40) 
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Figure 6 - Isolation of the fungus in the yeast form: yeast cells 
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